Abstract

OBJECTIVE:Explore the feasibility and safety of transcatheter closure of perimembranous ventricular septal defects using a wire-drifting technique (WT) in children.METHODS:We retrospectively analyzed 121 pediatric patients diagnosed with perimembranous ventricular septal defects who underwent interventional treatment at the First Affiliated Hospital of Xi'an Jiaotong University from Dec 2011 to Dec 2014. Based on the method used for arteriovenous loop establishment during the procedure, the patients were divided into a conventional technique (CT) group and a WT group.RESULTS:In total, 51 of the 53 patients (96.2%) in the CT group and 66 of the 68 patients (97.1%) in the WT group achieved procedural success, with no significant difference between the two groups (p>0.05). The CT group showed a nonsignificantly higher one-time success rate of arteriovenous loop establishment (94.3% vs. 91.2%, p>0.05). The procedure time was 46.0 (14.0) min and 46.5 (10.0) min in the CT and WT groups, respectively. The CT procedure was discontinued in the 2 cases (3.8%) of intraprocedural atrioventricular block in the CT group. In the one case (1.9%) of postprocedural atrioventricular block in the CT group, a permanent pacemaker was implanted to resolve third-degree atrioventricular block three months after the procedure. In the WT group, no cases of intraprocedural atrioventricular block occurred, and one case (1.5%) of postprocedural atrioventricular block occurred. In this case, intravenous dexamethasone injection for three days returned the sinus rhythm to normal. Aggravated mild to moderate tricuspid regurgitation was observed in 2 patients (3.8%) in the CT group during the 2-year follow-up period; aggravated tricuspid regurgitation was not observed in the WT group. During the 2-year follow-up period, there was no evidence of residual shunting in either group.CONCLUSION:Transcatheter closure of perimembranous ventricular septal defects with the WT is safe and effective in children.

Highlights

  • Since 2002, when Hijazi [1] first used the new Amplatzer occluder to treat perimembranous ventricular septal defects (PmVSD) and achieved success, transcatheter closure has become an effective method for the treatment of PmVSD [2,3]

  • Ventricular tachycardia, supraventricular tachycardia and even atrioventricular block (AVB) may occur during the procedure

  • The exact underlying mechanism of AVB remains speculative, but the occurrence of an AVB in the procedure when the arteriovenous loop was created suggests that the system of conduction was injurious

Read more

Summary

Introduction

Since 2002, when Hijazi [1] first used the new Amplatzer occluder to treat perimembranous ventricular septal defects (PmVSD) and achieved success, transcatheter closure has become an effective method for the treatment of PmVSD [2,3]. The transcatheter closure of ventricular septal defects (VSD) is not currently approved in the United States because of unacceptably high rates of heart block (2.9%–5.7%), both post-procedural and late-onset [3,4,5]. Received for publication on October 12, 2017. Accepted for publication on July 4, 2018

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call